A Study to Test the Efficacy and Safety of the Beta-3 Agonist Mirabegron (YM178) in Patients With Symptoms of Overactive Bladder
Clinical trial NCT00912964 · COMPLETED
Trial details
- NCT number
- NCT00912964
- Sponsor
- Astellas Pharma Inc
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2009-04-28
- Primary completion
- 2010-04-27
- Enrollment
- 2030
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.